Applied Therapeutics APLT
$ 9.82
6.05%
Quarterly report 2024-Q2
added 08-07-2024
Applied Therapeutics Income Statement 2011-2024 | APLT
Annual Income Statement Applied Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
541 M | 35.2 M | 78.8 M | 470 M | 682 M | - | - | - | - | - | - | - | - |
Shares |
84.2 M | 37.8 M | 25.6 M | 22.4 M | 12.8 M | - | - | - | - | - | - | - | - |
Historical Prices |
6.42 | 0.93 | 3.08 | 20.9 | 52.5 | - | - | - | - | - | - | - | - |
Net Income |
-120 M | -82.5 M | -106 M | -94 M | -45.5 M | -16.5 M | -4.28 M | - | - | - | - | - | - |
Revenue |
9.99 M | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-64.5 M | -83 M | -106 M | -94.5 M | -45.6 M | -13.5 M | - | - | - | - | - | - | - |
Interest Expense |
-27 K | -177 K | -521 K | -54 K | -24 K | -1.14 M | - | - | - | - | - | - | - |
EBITDA |
-64.5 M | -83 M | -106 M | -94.1 M | -45.6 M | -13.3 M | -4.28 M | - | - | - | - | - | - |
Operating Expenses |
74.5 M | 83 M | 106 M | 94.5 M | 45.6 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
20.6 M | 27.3 M | 43 M | 32.7 M | 13.2 M | 2.05 M | 582 K | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Applied Therapeutics
2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
144 M | 84.9 M | 90.7 M | 79 M | 56.4 M | 48.1 M | 48 M | 26.9 M | 26.2 M | 26.2 M | 26.2 M | 26.1 M | 24.1 M | 22.5 M | 22.4 M | 22.1 M | 20.8 M | 18.5 M | 17.1 M | 13.9 M | 5.51 M | 5.51 M | 5.5 M | 5.46 M | 5.46 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
2.9 M | - | -42.4 M | -29.6 M | -10.1 M | - | -19.1 M | -25.9 M | -23.1 M | - | -28.4 M | -25.8 M | -24.2 M | - | -29.8 M | -28.1 M | -12.4 M | - | -10.7 M | -8.44 M | -45.5 M | - | -4.28 M | -3.18 M | -2.34 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
144 K | - | - | - | 10.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-20.4 M | - | -15.5 M | -17.2 M | -10.9 M | - | -19.4 M | -21.5 M | -23.1 M | - | -28.4 M | -25.9 M | -24.2 M | - | -30 M | -28.3 M | -12.5 M | - | -10.7 M | -8.44 M | -8.73 M | - | -3.32 M | -2.34 M | -1.87 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-34 K | - | 10 K | -5 K | 31 K | - | -8 K | -90 K | -96 K | - | -64 K | -122 K | -56 K | - | -10 K | 38 K | -24 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-20.4 M | - | -15.5 M | -17.2 M | -10.9 M | - | -19.4 M | -21.5 M | -23.1 M | - | -28.4 M | -25.9 M | -24.2 M | - | -30 M | -28.3 M | -12.5 M | - | -10.7 M | -8.44 M | -8.73 M | - | -3.32 M | -2.34 M | -1.87 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
20.6 M | - | 15.5 M | 17.2 M | 21.5 M | - | 19.4 M | 21.5 M | 23.1 M | - | 28.4 M | 25.9 M | 24.2 M | - | 30 M | 28.3 M | 12.5 M | - | 10.7 M | 8.44 M | 8.73 M | - | 3.32 M | 2.34 M | 1.87 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
10.6 M | - | 4.71 M | 5.29 M | 5.58 M | - | 6.24 M | 6.12 M | 8.07 M | - | 10.8 M | 11.1 M | 9.75 M | - | 10 M | 7.52 M | 5.2 M | - | 3.29 M | 4.18 M | 1.86 M | - | 598 K | 400 K | 420 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency